Retalix Enters Japan: Drug-Eleven Selects Retalix StoreLine and ReMA for Rollout in its 169 Health & Beauty Stores
RA`ANANA, Israel, December 22, 2004 - Retalix Ltd. (Nasdaq: RTLX), today announced that Drug-Eleven in Japan has signed a contract to install Retalix StoreLine store solutions and REMA chain management platform throughout the chain. Drug Eleven is a leading Japanese health & beauty chain of 169 stores based in Fukouka.
The Retalix offering for Drug Eleven provides for advanced store operations and management activities hosted by a web-enabled suite of central applications, including item category management, promotions, loyalty, and data reporting and analysis.
The first Retalix installation at a Drug-Eleven store will go live in mid-2005, with the rollout to be completed by end of 2005, in cooperation with CPI (Create Power Inc.). CPI, which is affiliated with Sojitz Corporation, the large Japanese trading company, is responsible for the sales, service and support of Retalix products in Japan.
Mr. Tsuneo Okubo, President and CEO of Drug Eleven, said: "Drug Eleven selected Retalix for their technology and innovation leadership in the Health & Beauty retail environment, offering flexible and easy-to-use solutions, and a good understanding of the Japanese retail business requirements coupled with 24-hour local service and support.”
Mr. Hitoshi Shimase, Chairman of Create Power Inc. (CPI), said: “Retalix offers the opportunity to introduce the same advanced technologies it deploys with its well-known customers worldwide into the Japanese retail market”.
Yoni Stutzen, EVP International Business Division of Retalix Ltd., said: “This is a significant entry for Retalix into Japanese retail market, which is the second largest retail market after the US, hence meeting one of our most important growth goals set forth at the beginning of this year. This contract also demonstrates the Retalix capabilities of working successfully with strong local partners.”
About Drug Eleven
Drug Eleven is a leading Japanese health & beauty chain of 169 stores based in Fukouka. Drug Eleven has been in business since the early nineties, and is aiming its selection of health, beauty and pharmacy products to the medium- and high-income consumers. Drug Eleven plans to grow at a rate of 20 new stores per year during the next few years.
About Create Power Inc. (CPI)
Create Power Inc. (CPI) specializes in the sales, service and support of software solutions throughout Japan. CPI was established in 1996, employs about 60 staff, and has main offices in Tokyo and Nagasaki. CPI is affiliated with Sojitz Corporation, a large Japanese trading company, with a total of about 25,000 employees, which, among other things, holds the exclusive rights for brands such as Boeing and Nike in Japan.
Additional information is available at www.cpower.co.jp and also www.sojitz.com
About Retalix Ltd.
Retalix Ltd., with North American headquarters in Dallas, provides integrated enterprise-wide software solutions for the global food and fuel retail industries, including supermarkets, convenience stores, fuel stations and restaurants. The Company offers a full suite of software applications that support a food retailer`s essential retailing operations and enable retailers to increase their operating efficiencies while improving customer acquisition, retention and profitability. With installations in more than 33,000 stores and across 44 countries, the Company markets its software solutions through direct sales, distributors, local dealers and its various subsidiaries. For further information, please visit the Company`s web site at www.retalix.com
Safe Harbor for Forward-Looking Statements: Except for statements of historical fact, the information presented herein constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, including revenues, income and expenses, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include risks relating to the Company’s anticipated future financial performance, continued roll-outs with existing customers, the market reception of its new e-marketplace and ASP services, the potential benefits to food and fuel retailers and suppliers, expansion into new geographic markets, the conversion of sales leads into customers and the ramp-up of ASP users, the integration of the Company’s acquisition of OMI and other factors over which Retalix may have little or no control. This list is intended to identify only certain of the principal factors that could cause actual results to differ. Readers are referred to the reports and documents filed by Retalix with the Securities and Exchange Commission, including the Company’s Annual Report on Form 20-F for the year ended December 31, 2003, for a discussion of these and other important risk factors. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events.
Back...
